awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38205442-2E09F784-4AC2-4CCF-BF82-5604DA52417D
Q38205442-2E09F784-4AC2-4CCF-BF82-5604DA52417D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38205442-2E09F784-4AC2-4CCF-BF82-5604DA52417D
Efficacy and Safety Profile of Combining Sorafenib with Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer: A Meta-analysis
P2860
Q38205442-2E09F784-4AC2-4CCF-BF82-5604DA52417D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38205442-2E09F784-4AC2-4CCF-BF82-5604DA52417D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8b4e323f1b7dc50f4bca601501c7067f2b028565
P2860
Sorafenib in locally advanced or metastatic breast cancer.